Literature DB >> 21453048

Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition.

Martyn F Biddiscombe1, Sally N Meah, S Richard Underwood, Omar S Usmani.   

Abstract

BACKGROUND: Two-dimensional gamma scintigraphy is an important technique used to evaluate the lung deposition from inhaled therapeutic aerosols. Images are divided into regions of interest and deposition indices are derived to quantify aerosol distribution within the intrapulmonary airways. In this article, we compared the different approaches that have been historically used between different laboratories for geometrically defining lung regions of interest. We evaluated the effect of these different approaches on the derived indices classically used to assess inhaled aerosol deposition in the lungs. Our primary intention was to assess the ability of different regional lung templates to discriminate between central and peripheral airway deposition patterns generated by inhaling aerosols of different particle sizes.
METHODS: We investigated six methods most commonly reported in the scientific literature to define lung regions of interest and assessed how different each of the derived regional lung indices were between the methods to quantify regional lung deposition. We used monodisperse albuterol aerosols of differing particle size (1.5, 3, and 6 μm) in five mild asthmatic subjects [forced expiratory volume in 1 sec (FEV(1)) 90% predicted] to test the different approaches of each laboratory.
RESULTS: We observed the areas of geometry used to delineate central (C) and peripheral (P) lung regions of interest varied markedly between different laboratories. There was greater similarity between methods in values of penetration index (PI), defined as P/C aerosol counts normalized by P/C krypton ventilation counts, compared to nonnormalized C/P or P/C aerosol count-ratios. Normalizing the aerosol deposition P/C count-ratios by the ventilation P/C count-ratios, reduced the variability of the data. There was dependence of the regional lung deposition indices on the size of the P region of interest in that, as P increased, C/P count-ratios decreased and P/C count-ratios increased, whereas PI was less affected by variations in the P area. We found particle size, itself, strongly influenced the indices of regional aerosol deposition such that C/P count-ratios increased with increasing particle size for each method and conversely, P/C count-ratios and PI decreased.
CONCLUSIONS: Different approaches used to determine pulmonary regions of interest and quantify aerosol deposition produce different results. Our research highlights a genuine need for a consensus to standardize the methodology to facilitate data comparison between laboratories on aerosol deposition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453048     DOI: 10.1089/jamp.2010.0845

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  22 in total

1.  Heterogeneity of Particle Deposition by Pixel Analysis of 2D Gamma Scintigraphy Images.

Authors:  William D Bennett; Miao Xie; Kirby Zeman; Harry Hurd; Scott Donaldson
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-11-13       Impact factor: 2.849

2.  Airway deposition of nebulized gene delivery nanocomplexes monitored by radioimaging agents.

Authors:  Maria D I Manunta; Robin J McAnulty; Amy McDowell; Jing Jin; Deborah Ridout; John Fleming; Stephen E Bottoms; Livia Tossici-Bolt; Geoffrey J Laurent; Lorenzo Biassoni; Christopher O'Callaghan; Stephen L Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

3.  Bronchopulmonary pharmacokinetics of (R)-salbutamol and (S)-salbutamol enantiomers in pulmonary epithelial lining fluid and lung tissue of horses.

Authors:  Glenn A Jacobson; Sharanne Raidal; Kate Robson; Christian K Narkowicz; David S Nichols; E Haydn Walters
Journal:  Br J Clin Pharmacol       Date:  2017-02-08       Impact factor: 4.335

4.  Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.

Authors:  P Worth Longest; Geng Tian; Navvab Khajeh-Hosseini-Dalasm; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-04-15       Impact factor: 2.849

5.  Anatomically Based Analysis of Radioaerosol Distribution in Pulmonary Scintigraphy: A Feasibility Study in Asthmatics.

Authors:  Luciana Alcoforado; Armèle Dornelas de Andrade; Joaquin L Herraiz; Simone Cristina Soares Brandão; Jacqueline de Melo Barcelar; James B Fink; Jose G Venegas
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2018-04-19       Impact factor: 2.849

6.  Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.

Authors:  Geng Tian; Michael Hindle; Sau Lee; P Worth Longest
Journal:  Pharm Res       Date:  2015-05-06       Impact factor: 4.200

7.  Homogeneity of Aerosol Deposition and Mucociliary Clearance are Improved Following Ivacaftor Treatment in Cystic Fibrosis.

Authors:  William D Bennett; Kirby L Zeman; Beth L Laube; Jihong Wu; Gail Sharpless; Peter J Mogayzel; Scott H Donaldson
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-10-16       Impact factor: 2.849

8.  Comparison of 133 xenon ventilation equilibrium scan (XV) and 99m technetium transmission (TT) scan for use in regional lung analysis by 2D gamma scintigraphy in healthy and cystic fibrosis lungs.

Authors:  Kirby L Zeman; Jihong Wu; Scott H Donaldson; William D Bennett
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-02-19       Impact factor: 2.849

Review 9.  Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung.

Authors:  Chantal Darquenne; John S Fleming; Ira Katz; Andrew R Martin; Jeffry Schroeter; Omar S Usmani; Jose Venegas; Otmar Schmid
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-02-01       Impact factor: 2.849

10.  SARS-CoV-2-Laden Respiratory Aerosol Deposition in the Lung Alveolar-Interstitial Region Is a Potential Risk Factor for Severe Disease: A Modeling Study.

Authors:  Sabine Hofer; Norbert Hofstätter; Albert Duschl; Martin Himly
Journal:  J Pers Med       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.